Bills/H.R. 5160119th Congress

Stem Cell Therapeutic and Research Reauthorization Act of 2025

Senate: Received

Companion bill: S. 4109(Related bill)

Sponsor

RChristopher H. Smith(NJ)

Cosponsors

Introduced

2025-09-04

Last action

2026-07-21

Received in the Senate. Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 464.

Action Timeline

Jul 21, 2026SenateLatest
Received in the Senate. Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 464.
Jul 20, 2026House
Motion to reconsider laid on the table Agreed to without objection.
Jul 20, 2026House
On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H4642)
Jul 20, 2026House
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H4642)
Jul 20, 2026House
DEBATE - The House proceeded with forty minutes of debate on H.R. 5160.
Jul 20, 2026House
Considered under suspension of the rules. (consideration: CR H4642-4643)
Jul 20, 2026House
Mr. Guthrie moved to suspend the rules and pass the bill, as amended.
Jul 2, 2026House
Placed on the Union Calendar, Calendar No. 629.
Jul 2, 2026House
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 119-724.
May 21, 2026House
Ordered to be Reported (Amended) by the Yeas and Nays: 48 - 0.
May 21, 2026House
Committee Consideration and Mark-up Session Held
May 13, 2026House
Forwarded by Subcommittee to Full Committee by Voice Vote.
May 13, 2026House
Subcommittee Consideration and Mark-up Session Held
Sep 4, 2025House
Referred to the Subcommittee on Health.
Sep 4, 2025House
Referred to the House Committee on Energy and Commerce.
Sep 4, 2025House
Introduced in House

Official Sources

Topics

Policy area

Health

Legislative subjects

Biological and life sciencesBlood and blood diseasesCell biology and embryologyHealth programs administration and fundingOrgan and tissue donation and transplantation